🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Devi SenGupta

Gilead Sciences (United States)

ORCID: 0000-0003-3811-8111

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial”.

Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial

Nature Medicine(2022)10.1038/s41591-022-02060-2

N/A

1.2DataRank · unranked

72 citations

Anuska Llano, Samandhy Cedeño, Tuixent Escribà, Míriam Rosás-Umbert, Mariona Parera +34 more

Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021

Nature Medicine(2021)10.1038/s41591-021-01590-5

N/A

0.889DataRank · unranked

374 citations

Nancie M. Archin, Paula M. Cannon, Simon Collins, R. Brad Jones, Marein A.W.P. de Jong +74 more

Multi-stakeholder consensus on a target product profile for an HIV cure

The Lancet HIV(2020)10.1016/s2352-3018(20)30234-4

N/A

0.657DataRank · unranked

79 citations

Timothy Attoye, Cathy Bansbach, Brian Doehle, Karine Dubé, Mark Dybul +15 more

Correlates of HIV-1 control after combination immunotherapy

Nature(2025)10.1038/s41586-025-09929-5

N/A

0.654DataRank · unranked

28 citations

Demi Sandel, Amelia N. Deitchman, Sang‐In Kim, Thomas Dalhuisen, Hari Prabhath Tummala +35 more

Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: An individual data-based meta-analysis of 24 prospective studies

Research Square(2024)10.21203/rs.3.rs-5065764/v1

N/A

0.104DataRank · unranked

1 citations

Jesal Gohil, Jonathan Z. Li, Ronald J. Bosch, Andrea J. White, Catherine Seamon +26 more

Predictors of virological outcomes after analytical interruption of antiretroviral therapy and HTI vaccination in early treated people with HIV-1._

Communications Medicine(2025)10.1038/s43856-025-01266-y

N/A

0DataRank · unranked

1 citations

Yovaninna Alarcón‐Soto, José Ramón Arribas, Adrián Curran, Anuska Llano, Samandhy Cedeño +11 more

Predictors of virological outcomes after analytical interruption of antiretroviral therapy following immune interventions with HTI vaccines in early-treated people with HIV: a pooled analysis from the AELIX-002 and AELIX-003 clinical trials

Research Square(2025)10.21203/rs.3.rs-6567488/v1

N/A

0DataRank · unranked

0 citations

Yovaninna Alarcón‐Soto, José Ramón Arribas, Adrián Curran, Anuska Llano, Samandhy Cedeño +11 more

561. Safety of Remdesivir vs Standard Care in Patients with Moderate Covid-19

Open Forum Infectious Diseases(2020)10.1093/ofid/ofaa439.755

N/A

0DataRank · unranked

5 citations

Mi Young Ahn, Gregory Huhn, Aruna Subramanian, Carlos Lumbreras, Stefan Schmiedel +15 more

The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy

Science Translational Medicine(2021)10.1126/scitranslmed.abg3071

N/A

0DataRank · unranked

78 citations

Cynthia Brinson, Edwin DeJesus, Anthony Mills, Peter Shalit, Susan Guo +19 more

Early Viral Dynamics Predict Human Immunodeficiency Virus Posttreatment Control After Analytic Treatment Interruption

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae551

N/A

0DataRank · unranked

4 citations

Elena Vendrame, Devi SenGupta, Romas Geleziunas, Susan J. Little, Davey M. Smith +9 more

Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies

Nature Communications(2025)10.1038/s41467-025-56116-1

N/A

0DataRank · unranked

55 citations

Jesal Gohil, Jonathan Z. Li, Ronald J. Bosch, Caitlin White, Tae‐Wook Chun +25 more